Davis's Drug Guide
sodium phenylbutyrate/taurursodiol
General
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
sow-dee-um fen-il-byoo-ti-rate/taur-ur-so-dye-ol
Trade Name(s)
- Relyvrio
Ther. Class.
agents for amyotrophic lateral sclerosis
Pharm. Class.
histone deacetylase inhibitors
bile acid replacements
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Sodium Phenylbutyrate/taurursodiol." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110923/all/sodium_phenylbutyrate_taurursodiol.
Vallerand AHA, Sanoski CAC, Quiring CC. Sodium phenylbutyrate/taurursodiol. Davis's Drug Guide. F.A. Davis Company; 2023. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110923/all/sodium_phenylbutyrate_taurursodiol. Accessed July 26, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Sodium phenylbutyrate/taurursodiol. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110923/all/sodium_phenylbutyrate_taurursodiol
Vallerand AHA, Sanoski CAC, Quiring CC. Sodium Phenylbutyrate/taurursodiol [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 July 26]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110923/all/sodium_phenylbutyrate_taurursodiol.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - sodium phenylbutyrate/taurursodiol
ID - 110923
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110923/all/sodium_phenylbutyrate_taurursodiol
PB - F.A. Davis Company
ET - 18
DB - Pediatrics Central
DP - Unbound Medicine
ER -
